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1st Place Oral Research Winner - Cognitive Heuristic
Availability Bias in the Emergency Room?
Jingjin Chen 1, Verna Curfman 2, Abu Omar Samah 3, Jiling Chou 4,
David Weisman 3
1
MedStar Health, Baltimore, MD;
2
Georgetown University School of Medicine;
3
MedStar Health Baltimore, Internal Medicine;
4
MedStar Health Research

Background: A previous study found that 3% of emergency room (ED)
physicians are responsible for ordering a large portion (32%) of computer tomography pulmonary angiography (CTPA) scans for evaluation of pulmonary embolisms (PE) with a low positive scan rate (PSR)
of 5.5%. We hypothesized that this high rate of scan ordering may be
due to availability bias.
Purpose for study/Hypothesis: To evaluate if the number of CTPA
ordering is associated with availability bias.
Methods: This was a multisite medical system retrospective cohort
study. All CTPAs ordered by ED attending’s at MedStar Health in
2017 were included in the analysis. There is no positive scan in the
30-day run-in period before Day 0. Total count of orders at Day 15
and Day 30 were collected. Each physician has one observation
period in each quarter. The inclusion criteria include: 1) ED physicians who had ordered 30 CTPAs in 2017; 2) 30 days of subsequent
data should be available. We categorized the physicians into 1) highutilizers (the top 30% of physicians ordered the most scans); 2) lowutilizers (the remainders); and 3) high-utilizers with low PSR (PSR <
15%). Linear regression was utilized to assess the difference of percentages of CTPAs ordered after a positive scan between the two
groups. We considered a two-tailed p value of below 0.05 as statistically signiﬁcant.
Results: There was no signiﬁcant difference of number of CTPA orders
among ED physicians in general or comparing the high-utilizers and
low-utilizers on the ordering rates following a positive scan. However,
on average the high-utilizers with low PSR ordered more than double
number of scans when comparing the low-utilizers (18 vs. 8.5) in year
2017. Among those scans, 59.2% were ordered after a positive scan,
while only 45% were ordered after a positive scan among other ED
doctors. This 14% difference is signiﬁcant (p¼0.025).
Discussion/Conclusion: Our data showed that the high-utilizers,
especially those with low PSR, ordered signiﬁcantly more CTPAs after
a positive scan. A study conducted in California also found a 15% increase in physician ordering after a positive scan. Our study supports
our hypothesis that high utilizers with low PSR are more subject to

availability bias than their colleagues. The limitations include we have
no knowledge on how the pretest protocols were employed consistently and whether a patient had a recent PE diagnosis. Further studies
could be done to determine the role of availability bias in decision
making and explore interventions to eliminate this bias.

1st Place Research Poster Winner - Coronary Artery
Calcium Scores Among Older Adults with Diabetes
and their Relationship with Diabetes-Speciﬁc Risk
Enhancers – the Atherosclerosis Risk in Communities
(ARIC) Study
Olufunmilayo H. Obisesan 1, Olusola A. Orimoloye, MD,
Frances M. Wang, MS, Zeina A. Dardari, MS, Elizabeth Selvin, PhD,
Ellen Boakye, MD, Albert D. Osei, MD, Yasuyuki Honda, MD,
S.M. Iftekhar Uddin, MBBS, Omar Dzaye, MD, James Pankow, PhD,
Josef Coresh, MD, Candace M. Howard-Claudio, MD,
Khurram Nasir, MD, Kunihiro Matsushita, MD, Michael J. Blaha, MD
1
MedStar Union Memorial Hospital, MD
Objective: To examine the distribution of coronary artery calcium
(CAC) scores, among older adults with diabetes and their association
with diabetes speciﬁc risk enhancers.
Methods: We conducted a cross-sectional analysis of 422 coronary
heart disease (CHD)-free participants with diabetes, aged 75years
who had CAC scans at visit 7 (2018-2019) of the Atherosclerosis Risk in
Communities (ARIC) study. CAC distribution was reported by sex,
and multivariable-adjusted logistic regression models were used to
estimate the association between diabetes risk enhancers [duration of
diabetes (10 years vs <10yrs); albuminuria (30mcg vs <30mcg);
eGFR (<60mL/min/1.73m2 vs >60mL/min/1.732m2); retinopathy
(present vs absent); neuropathy (present vs absent); Ankle-brachial
index (<0.9 vs 0.9)] and CAC, adjusting for age, sex, race, education
level, dyslipidemia, hypertension, physical activity, smoking status,
and family history of CHD.
Results: A total of 422 participants (mean age:79.9 [SD:3.97] years,
56.6% female, 62.1% White) were studied. 94.6% participants had
CAC>0, and the distribution of CAC scores was heterogenous
across sex strata. We noted a graded increase in median CAC score
with increasing number of diabetes risk enhancers, especially in
males. Individuals with 2 diabetes risk enhancers had greater
odds of elevated CAC compared to those with <2 (OR 2.00
[1.18,3.39]).
Conclusion: The distribution of CAC remains heterogenous even
among older adults with diabetes and is strongly associated with the
number of diabetes risk enhancers present. This has possible value for
risk stratiﬁcation and may guide intensity/de-escalation of statins in
this population.

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12(6):119–121

An 87-year-old woman with a history of AF and chronic kidney disease
stage IV was brought into the emergency department after being found
unresponsive. She was diaphoretic, bradypneic with a respiratory rate
of eight breaths per minute, and hypoxic with an oxygen saturation
level of 80% requiring 12L via nonrebreather mask. Other vital signs
were stable. Laboratory data was remarkable for serum creatinine of
2.9 mg/dL, consistent with her baseline. Electrocardiogram showed AF
and new wide QRS complexes (162 milliseconds) with a left bundle
morphology. Since the patient was on propafenone 150 mg three times
daily with impaired renal function, suspicion for propafenone toxicity
was raised. Propafenone was discontinued immediately, and a level
was sent nine hours after her last dose. The Poison Control Center was
contacted, and she was started on a continuous infusion of sodium
bicarbonate. Within four hours of initiation of sodium bicarbonate
infusion, there was narrowing of the QRS complexes to baseline and
resolution of altered mental status. The propafenone level returned
one week later at 0.96 mcg/ml (therapeutic range 0.5-2.0 mcg/ml).
Propafenone toxicity is an elusive diagnosis that most commonly
presents with cardiac manifestations including widened QRS complexes, dysrhythmias, hypotension, bradycardia or heart block. In the
geriatric population, it has been documented to affect the central
nervous system leading to alteration in mental status or behavioral
changes. Cases of toxicity have been documented with doses ranging
from 625 mg daily up to 8.1 g in one ingestion. Current case reports of
toxicity only include patients with supratherapeutic levels; our patient
presented with signs and symptoms of propafenone toxicity despite
having a level on the lower end of the therapeutic range. This case
highlights that propafenone toxicity can manifest even at levels
traditionally considered within the normal therapeutic range and at
total daily doses as low as 450 mg daily. This case also highlights the
need for judicious prescription of propafenone and other class IC
antiarrhythmics in the geriatric population.

1st Place Oral Clinical Vignette Winner - Raccoon Eyes
may Indicate Lethal AL Amyloidosis
Surendra Sapkota 1, Anshuta Beeram, Bhargavi Pulluri
1
Ascension Saint Agnes Hospital, MD

Introduction: Although ‘raccoon eyes’ is a well-known manifestation
of amyloidosis; it is only present in a minority of patients. Studies have
shown that patients have non-speciﬁc symptoms, such as fatigue, but
those with primary cardiac involvement are more likely to have a delay
in diagnosis as compared to those with primary kidney involvement.
Delays in diagnosis have a signiﬁcant effect on prognosis.
Case: A 65-year-old male presented with random bruising in the upper
chest and around the eyes for one and a half years. Physical examination was unremarkable except for neck ecchymoses. Work up for
bleeding diathesis including PT/INR/PTT, ﬁbrinogen, factor VIII, factor XIII and Von Willebrand testing was unremarkable. Serum electrophoresis showed an M spike, serum kappa light chain level was
22mg/L, serum lambda light chain level was 344 mg/dl and a kappa to
lambda ratio was 0.06. 24-hour urine Bence-Jones protein was 205 mg/
day, urine immunoﬁxation showed monoclonal free lambda light
chain. Factor X activity was 42%. Bone marrow biopsy showed 10%
plasma cells, Congo red stain was positive for amyloid protein, (11:14)
translocation was positive. NT-proBNP was 1503 pg/ml. Strain echocardiogram showed left ventricular hypertrophy, ejection fraction 6570%, and 57% strain. Cardiac magnetic resonance imaging showed
concentric left ventricular hypertrophy and diffuse right and left
ventricle subendocardial late gadolinium enhancement consistent
with cardiac amyloidosis. He was started on systemic therapy with a
regimen of daratumumab, cyclophosphamide, bortezomib and dexamethasone. After one cycle of therapy, lambda light chain levels
normalized, and he had improvement in bruising. He continues to
receive systemic therapy in conjunction with cardiology follow up.
Discussion: Light-chain (AL) amyloidosis is a lethal form of systemic
amyloidosis arising from clonal expansion of CD38+ plasma cells.
Organ damage occurs when these plasma cells produce misfolded
immunoglobulin light chains, which form amyloid ﬁbrils and are
deposited in tissues. A minority of AL amyloidosis patients display
‘raccoon eyes’ caused by increased vascular fragility, a side effect of
amyloid ﬁbril accumulation. Amyloidosis can be directly associated
with a bleeding diathesis due to factor X deﬁciency since factor X binds
to amyloid ﬁbrils primarily in the liver and spleen. Other important
pathogenetic factors in AL amyloidosis include acquired hemostatic
abnormalities, coagulation factor deﬁciencies, hyperﬁbrinolysis, and
platelet dysfunction. Diagnostic delays for patients with cardiac
involvement is detrimental as the median survival rate among these
patients without treatment is approximately 6 months after the onset of
symptoms but timely treatment can prevent organ damage.

1st Place Chief resident Award Poster Clinical Vignette
Winner - In Cardiac Dis-Dress: A Rare Case of DRESSassociated Acute Necrotizing Eosinophilic Myocarditis
Jonaphine Rae Mata 1, Ryan Wallace
1
Johns Hopkins, MD

DRESS syndrome is a delayed type IV hypersensitivity and multisystem reaction to a drug. It is characterized by a skin rash, fever and
organ involvement usually 2-3 weeks after initiation of an inciting
medication. Acute Necrotizing Eosinophilic Myocarditis (ANEM) as a
sequalae of DRESS is rare, and late recognition of this important
ﬁnding can be fatal.
We present a case of a 37-year-old female with a past medical history of
DRESS due to Sulfasalazine and Psoriatic Arthritis who presents with
intermittent left-sided chest pain radiating to the left shoulder alleviated by leaning forward, worsened by recumbency, as well as worsening dyspnea and lower extremity edema. Three weeks prior to this
presentation, the patient was diagnosed with DRESS syndrome due to
Sulfasalazine and discharged on Cyclosporine and a month-long
Prednisone taper. Physical exam showed JVP to the mandible and
lower extremity edema. Labs were notable for troponin and Pro-BNP
elevation. A transthoracic echo (TTE) showed biventricular failure and
reduced left ventricular ejection fraction (LVEF) of 20-25%, with a
moderate pericardial effusion. She was diuresed with IV Furosemide,
continued on Cyclosporine and started on high dose steroids. We
obtained a cardiac MRI and cardiac biopsy which were diagnostic for
ANEM. A right heart catheterization (RHC) showed elevated rightand left-sided pressures and a cardiac index of 1.28 L/min/m2, thus
spurring dobutamine-assisted diuresis. However, the patient
continued to show signs of progressive cardiogenic shock with

1st Place Clinical Vignette Poster Winner - Propafenone:
Pocket-Pill or Poison?
Rawan Amir 1, Seyed Hossein Aalaei-Andabili, Zachary Noel,
Benjamin Remo, Vincent See, Libin Wang
1
University of Maryland Medical Center, MD

Propafenone is a class IC antiarrhythmic drug used for the treatment of
supraventricular tachycardia. It can be used as a “pill-in-pocket”
approach or as daily maintenance therapy to maintain sinus rhythm in
patients with atrial ﬁbrillation (AF). Herein, we discuss a case of
propafenone toxicity in an older adult despite therapeutic drug level.
This case is the ﬁrst to report propafenone toxicity within the accepted
therapeutic range.
120
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ANEM is a serious sequelae of DRESS syndrome with high rates of
morbidity and mortality. Early recognition is key, and fatal progression
can be the consequence of delayed treatment. As demonstrated by this
case, patients with DRESS syndrome should be monitored and
screened early for cardiac involvement. Treatment should involve
prompt initiation of immunosuppressants and multidisciplinary care
is important for a successful outcome.

worsening hemodynamic values on RHC, necessitating IABP placement and subsequent VA-ECMO cannulization. With improvement in
her hemodynamics, she was decannulated off VA-ECMO and weaned
off of dobutamine-assisted diuresis. Repeat TTE showed LVEF recovery to 40%, with continued mild global hypokinesis. On discharge,
we prescribed a prolonged prednisone taper, continued Cyclosporine
and initiated guideline directed medical therapy for heart failure.
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